Search results
James E. Van Horn
The National Law Review· 4 days agoJames "Jim" Van Horn focuses his practice on restructuring and insolvency law. Jim is ranked as a Band 1 bankruptcy/restructuring attorney by Chambers USA and is named to The Best Lawyers in ...
Morgan Stanley Is Doubling Down on Chinese EV Stocks
InvestorPlace· 6 days agoChinese EV stocks have been among the most beaten-down assets in the market. Whether we’re talking about Nio (NYSE:NIO), XPeng (NYSE:XPEV) or Li Auto...
Grocery Prices 2024: When Will Things Start to Get Cheaper Again at the Supermarket?
InvestorPlace· 7 days agoIf you have been to the grocery or supermarket recently, you might notice a lot of price increases...
Why Nvidia Stock Is STILL a Bargain for Long-Term Investors
InvestorPlace· 3 days agoNvidia (NASDAQ:NVDA) stock has seen a 16% drop this month, but remains a buy on the dips. Despite...
Council Post: Business Mergers 101 For Small-Business Owners
Forbes· 3 days agoIn the competitive business arena, merging companies is a strategy many consider a shortcut to...
Crypto Carnage Ahead? 3 Tokens to Dump Before the Bloodbath
InvestorPlace· 2 days agoUltimately, over the long term, the crypto projects likely to generate meaningful and sustainable...
Cognitive Health Research Leads to a Flourishing Serine Amino Acid Market with a CAGR of 7.2% by...
Benzinga· 2 days agoFMI predicts a promising future for the serine amino acid market (US$302 million by 2034) driven by L-serine's vital role in brain development and function. L-serine's benefits for neurological health fuel market
Why Is SoFi (SOFI) Stock Down 10% Today?
InvestorPlace· 3 days agoInvestors in SoFi Technologies (NASDAQ:SOFI) have certainly had it rough over the past year. Shares of SOFI stock are down more than 25% year-to-date...
3 Meme Stocks to Buy on the Dip: April 2024
InvestorPlace· 18 hours agoMany of yesterday’s meme stocks to buy, once the darlings of speculative traders, now languish as forgotten relics at the bottom of portfolios, their...
Stoke Therapeutics names new CFO amid growth phase By Investing.com
Investing.com· 3 days agoStoke Therapeutics, Inc. (NASDAQ:STOK), a biotechnology company focusing on RNA-based medicines for...
